PK is activated within the vasculature and releases bradykinin, the latter binds to bradykinin B2 receptors to enhance vascular permeability, triggering pain and pulmonary edema.47 Therefore, inhibition of PK might be a potential strategy to prevent acute respiratory distress syndrome.40 The gene discussed is BDKRB2; the disease is acute respiratory distress syndrome.